Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter P Toth

Showing results (261-270 of 425) with videos related to

Pageof 43
Sort By:
Current Medical Research and Opinion|August 9, 2017
Low-density lipoprotein 4: a novel predictor of coronary artery disease severityRahul Chaudhary, Denny Mathew, Kevin Bliden, et al.
Vascular Health and Risk Management|February 15, 2018
Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular diseaseThomas P Power, Xuehua Ke, Zhenxiang Zhao, et al.
Journal of the American College of Cardiology|April 9, 2024
An "Inclisiran First" Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular DiseaseMichael J Koren, Fatima Rodriguez, Cara East, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 14, 2022
Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart AssociationP Barton Duell, Francine K Welty, Michael Miller, et al.
Archives of Cardiovascular Diseases|September 3, 2020
Lipid-lowering treatment and low-density lipoprotein cholesterol target achievement in patients with type 2 diabetes and acute coronary syndromeJean Ferrières, Dominik Lautsch, Peter Bramlage, et al.
Atherosclerosis|August 6, 2016
Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practiceAlberico L Catapano, Dominik Lautsch, Lale Tokgözoglu, et al.
Hypertension (Dallas, Tex. : 1979)|June 28, 2017
Blood Pressure, Antihypertensive Polypharmacy, Frailty, and Risk for Serious Fall Injuries Among Older Treated Adults With HypertensionSamantha G Bromfield, Cedric-Anthony Ngameni, Lisandro D Colantonio, et al.
Journal of Clinical Lipidology|August 23, 2017
Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysisKamal Awad, Maria-Corina Serban, Peter Penson, et al.
Journal of Clinical Lipidology|February 18, 2014
Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular diseasePeter P Toth, Joanne M Foody, Joanne E Tomassini, et al.
The American Journal of Cardiology|April 18, 2024
GlycA Levels Independently Predict Coronary Artery Calcium Incidence and Progression in the ELSA-Brasil Cohort (Brazilian Longitudinal Study of Adult Health)Ronaldo C Fabiano Filho, Giuliano Generoso, Rhanderson Cardoso, et al.
Pageof 43

Showing results (261-270 of 425) with videos related to

Sort By:
Pageof 43
Current Medical Research and Opinion|August 9, 2017
Low-density lipoprotein 4: a novel predictor of coronary artery disease severityRahul Chaudhary, Denny Mathew, Kevin Bliden, et al.
Vascular Health and Risk Management|February 15, 2018
Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular diseaseThomas P Power, Xuehua Ke, Zhenxiang Zhao, et al.
Journal of the American College of Cardiology|April 9, 2024
An "Inclisiran First" Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular DiseaseMichael J Koren, Fatima Rodriguez, Cara East, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|April 14, 2022
Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart AssociationP Barton Duell, Francine K Welty, Michael Miller, et al.
Archives of Cardiovascular Diseases|September 3, 2020
Lipid-lowering treatment and low-density lipoprotein cholesterol target achievement in patients with type 2 diabetes and acute coronary syndromeJean Ferrières, Dominik Lautsch, Peter Bramlage, et al.
Atherosclerosis|August 6, 2016
Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practiceAlberico L Catapano, Dominik Lautsch, Lale Tokgözoglu, et al.
Hypertension (Dallas, Tex. : 1979)|June 28, 2017
Blood Pressure, Antihypertensive Polypharmacy, Frailty, and Risk for Serious Fall Injuries Among Older Treated Adults With HypertensionSamantha G Bromfield, Cedric-Anthony Ngameni, Lisandro D Colantonio, et al.
Journal of Clinical Lipidology|August 23, 2017
Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysisKamal Awad, Maria-Corina Serban, Peter Penson, et al.
Journal of Clinical Lipidology|February 18, 2014
Therapeutic practice patterns related to statin potency and ezetimibe/simvastatin combination therapies in lowering LDL-C in patients with high-risk cardiovascular diseasePeter P Toth, Joanne M Foody, Joanne E Tomassini, et al.
The American Journal of Cardiology|April 18, 2024
GlycA Levels Independently Predict Coronary Artery Calcium Incidence and Progression in the ELSA-Brasil Cohort (Brazilian Longitudinal Study of Adult Health)Ronaldo C Fabiano Filho, Giuliano Generoso, Rhanderson Cardoso, et al.
Pageof 43